Search results
Russia "heavily overestimated" Ukraine gains amid offensive push: ISW
Newsweek· 5 hours agoRussia's newly installed defense minister "heavily overestimated Russian advances in Ukraine" since...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 31 minutes agoKaryopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During ...
Ukraine war: Can using Western weapons on Russia change the war?
BBC News· 3 hours agoWill using Western weapons on Russia help Ukraine change the war? Ukraine is now allowed to use...
US tells Ukraine it can’t use its Atacms missiles inside Russia
The Telegraph via Yahoo News· 5 hours agoOutgunned and outmanned on the battlefield, Kyiv has been increasing pressure on its Western allies...
Astonishing Study Shows Evolution Really Does Repeat Itself
ScienceAlert via Yahoo News· 52 minutes agoThere certainly seems to be a stack of examples now, from moths and butterflies to fish, finches, sheep, and deer, of species following predictable evolutionary paths, returning to tested traits ...
Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors...
KOLR - KSFX Ozarks· 10 hours agoEli Lilly and Company (NYSE: LLY) today announced updated data from the Phase 1/2 clinical trial evaluating olomorasib as a monotherapy in patients with KRAS G12C-mutant advanced< ...
G1 Therapeutics seeks partner to advance cancer treatment - Triangle Business Journal
The Business Journals· 2 days agoA biopharmaceutical company in Research Triangle Park is looking for a partner to advance one of its...
Russia's creeping advance is costing it 1,200 soldiers a day: Western intel
INSIDER via Yahoo News· 1 day agoJust Thursday, the Institute for the Study of War, a Washington DC-based think tank, wrote that...
Blue Angels are headed to Indiana for the Terre Haute Air Show Saturday. What to know
Pensacola News Journal via Yahoo News· 13 hours agoGeneral admission tickets for the 2024 Terre Haute Air Show are $30 in advance and $40 at the gate,...
First results from late-breaking Phase 3 PALOMA-3 study show five-fold reduction in infusion-related...
The Parsons Sun· 1 day agoJohnson & Johnson announced today first data from the Phase 3 PALOMA-3 study evaluating subcutaneous (SC) amivantamab combined with lazertinib in patients with locally < ...
